Novel adapter CAR-T cell technology for precisely controllable multiplex cancer targeting

Chimeric antigen receptor (CAR)-T therapy holds great promise to sustainably improve cancer treatment. However, currently, a broad applicability of CAR-T cell therapies is hampered by limited CAR-T cell versatility and tractability and the lack of exclusive target antigens to discriminate cancerous...

Descripción completa

Detalles Bibliográficos
Autores principales: Seitz, Christian M., Mittelstaet, Joerg, Atar, Daniel, Hau, Jana, Reiter, Selina, Illi, Clara, Kieble, Verena, Engert, Fabian, Drees, Britta, Bender, Giulia, Krahl, Ann-Christin, Knopf, Philipp, Schroeder, Sarah, Paulsen, Nikolas, Rokhvarguer, Alexander, Scheuermann, Sophia, Rapp, Elena, Mast, Anna-Sophia, Rabsteyn, Armin, Schleicher, Sabine, Grote, Stefan, Schilbach, Karin, Kneilling, Manfred, Pichler, Bernd, Lock, Dominik, Kotter, Bettina, Dapa, Sandra, Miltenyi, Stefan, Kaiser, Andrew, Lang, Peter, Handgretinger, Rupert, Schlegel, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172918/
https://www.ncbi.nlm.nih.gov/pubmed/35686214
http://dx.doi.org/10.1080/2162402X.2021.2003532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172918/
https://www.ncbi.nlm.nih.gov/pubmed/35686214
http://dx.doi.org/10.1080/2162402X.2021.2003532

Ejemplares similares